2018
DOI: 10.1038/nrgastro.2018.7
|View full text |Cite
|
Sign up to set email alerts
|

Advances in the diagnosis and classification of gastric and intestinal motility disorders

Abstract: © 2 0 1 8 M a c m i l l a n P u b l i s h e r s L i m i t e d , p a r t o f S p r i n g e r N a t u r e . A l l r i g h t s r e s e r v e d .on already available consensus statements 3,4 . Consensus statements from other gastrointestinal societies or expert groups were searched for and included when appropriate, for example, if they were published more recently or if they covered relevant areas not specifically addressed in the previous documents 3,4 . Moreover, an updated literature search using PubMed and Me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
169
1
10

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 192 publications
(181 citation statements)
references
References 155 publications
(187 reference statements)
1
169
1
10
Order By: Relevance
“…Nevertheless, as the rate of GE is pivotal in determining postprandial glycaemia, its measurement will still be of great importance in diabetes patients, especially those presenting with unexplained fluctuations in blood glucose levels . Consequently, the latest consensus statement on investigation of gastric motility recommends GE studies to be performed in patients with poorly controlled diabetes . Furthermore, as clinical presentation alone can rarely differentiate between rapid and delayed emptying, it is recommended to determine GE in patients with symptoms compatible with gastroparesis, where upper GI endoscopy has not provided an explanatory diagnosis .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, as the rate of GE is pivotal in determining postprandial glycaemia, its measurement will still be of great importance in diabetes patients, especially those presenting with unexplained fluctuations in blood glucose levels . Consequently, the latest consensus statement on investigation of gastric motility recommends GE studies to be performed in patients with poorly controlled diabetes . Furthermore, as clinical presentation alone can rarely differentiate between rapid and delayed emptying, it is recommended to determine GE in patients with symptoms compatible with gastroparesis, where upper GI endoscopy has not provided an explanatory diagnosis .…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, the latest consensus statement on investigation of gastric motility recommends GE studies to be performed in patients with poorly controlled diabetes . Furthermore, as clinical presentation alone can rarely differentiate between rapid and delayed emptying, it is recommended to determine GE in patients with symptoms compatible with gastroparesis, where upper GI endoscopy has not provided an explanatory diagnosis . This is important, as the two entities of rapid or delayed GE may respond to entirely different therapeutic approaches …”
Section: Discussionmentioning
confidence: 99%
“…11 One such commercially available system is the wireless motility capsule (WMC; SmartPill, Medtronic, USA), which measures whole gut and regional transit times using stereotypical changes in pH to identify the capsule's progression from one GI region to the next. 6,11 Such information can be obtained using the Motilis 3D-Transit system (Motilis Medica, SA, Lausanne, Switzerland), an emerging research tool that tracks the location and orientation of up to three ingestible electromagnetic capsules. 6,11 Such information can be obtained using the Motilis 3D-Transit system (Motilis Medica, SA, Lausanne, Switzerland), an emerging research tool that tracks the location and orientation of up to three ingestible electromagnetic capsules.…”
Section: Introductionmentioning
confidence: 99%
“…Even extra‐GI disorders, such as diabetes mellitus and autoimmune disorders, may also show abnormalities to IEVB structure and function . Although neuro‐ICC‐muscular abnormalities represent a major factor in the pathogenesis of gut dysfunction and symptom generation in CIPO, the role of enteric luminal mechanisms, and in particular of IEVB, has never been explored in such patients. In this study, we addressed whether changes of TJ components occur in CIPO, and the possible correlations of identified IEVB‐related molecular changes to main clinical features and investigated the possible implication of mast cell infiltration, glial activation, VIP expression in IEVB integrity.…”
Section: Discussionmentioning
confidence: 88%
“…Before use, slides were deparaffinized in xylene, dehydrated through graded ethanol (both from Merck KGaA), and washed thoroughly in phosphate‐buffered saline (137mmol/L NaCl, 0.27 × 10 −3 % 2mmol/L KH 2 PO 4 ; 10mmol/L Na 2 HPO 4 ; pH 7.4, all salts purchased from Merck KGaA). To provide an adequate assessment of the neuromuscular component, sections were processed for histochemical and immunohistochemical analysis as established by guidelines from an International working team and applied in a recently published paper . Antisera were used to identify different components of the gut tissue with HRP/DAB standard method using the immunoperoxidase secondary detection system IHC Select HRP/DAB (Merck KGaA).…”
Section: Methodsmentioning
confidence: 99%